Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation.
Marie-Lena I E HarwardtMark S SchröderYunqing LiSebastian MalkuschPetra FreundShashi GuptaNebojsa JanjicSebastian StraussRalf JungmannMarina S DietzMike HeilemannPublished in: International journal of molecular sciences (2020)
Receptor tyrosine kinases (RTKs) orchestrate cell motility and differentiation. Deregulated RTKs may promote cancer and are prime targets for specific inhibitors. Increasing evidence indicates that resistance to inhibitor treatment involves receptor cross-interactions circumventing inhibition of one RTK by activating alternative signaling pathways. Here, we used single-molecule super-resolution microscopy to simultaneously visualize single MET and epidermal growth factor receptor (EGFR) clusters in two cancer cell lines, HeLa and BT-20, in fixed and living cells. We found heteromeric receptor clusters of EGFR and MET in both cell types, promoted by ligand activation. Single-protein tracking experiments in living cells revealed that both MET and EGFR respond to their cognate as well as non-cognate ligands by slower diffusion. In summary, for the first time, we present static as well as dynamic evidence of the presence of heteromeric clusters of MET and EGFR on the cell membrane that correlates with the relative surface expression levels of the two receptors.
Keyphrases
- single molecule
- tyrosine kinase
- epidermal growth factor receptor
- living cells
- advanced non small cell lung cancer
- atomic force microscopy
- single cell
- papillary thyroid
- small cell lung cancer
- signaling pathway
- fluorescent probe
- binding protein
- squamous cell
- poor prognosis
- heat shock
- squamous cell carcinoma
- oxidative stress
- cell death
- epithelial mesenchymal transition
- high resolution
- pseudomonas aeruginosa
- candida albicans
- cell proliferation
- cystic fibrosis
- optical coherence tomography
- induced apoptosis
- lymph node metastasis
- endoplasmic reticulum stress
- high speed
- amino acid
- combination therapy